Efficacy of artesunate-mefloquine for chloroquine-resistant Plasmodium vivax malaria in Malaysia: An open-label, randomized, controlled trial. by Grigg, M, William, T, Menon, J, Barber, B, Wilkes, C, Rajahram, G, Edstein, M, Auburn, S, Price, R, Yeo, T, Anstey, N

A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (... by Grigg, M, William, T, Dhanaraj, P, Menon, J, Barber, B, von Seidlein, L, Rajahram, G, Price, R, Anstey, N, Yeo, T

Artemether-lumefantrine versus chloroquine for the treatment of uncomplicated Plasmodium knowlesi malaria (CAN KNOW): an open-label randomized controlled trial by Grigg, M, William, T, Barber, B, Rajahram, G, Menon, J, Schimann, E, Wilkes, C, Patel, K, Chandna, A, Price, R, Yeo, T, Anstey, N

Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia: in vivo therapeutic efficacy and kelch13 molecular marker surveillance by Grigg, M, William, T, Piera, K, Rajahram, G, Jelip, J, Aziz, A, Menon, J, Marfurt, J, Price, R, Auburn, S, Barber, B, Yeo, T, Anstey, N

Age-related clinical spectrum of plasmodium knowlesi malaria and predictors of severity by Grigg, M, William, T, Barber, B, Rajahram, G, Menon, J, Schimann, E, Piera, K, Wilkes, C, Patel, K, Chandna, A, Drakeley, C, Yeo, T, Anstey, N

Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): An open-label, randomised controlled trial by Grigg, M, William, T, Menon, J, Dhanaraj, P, Barber, B, Wilkes, C, von Seidlein, L, Rajahram, G, Pasay, C, McCarthy, J, Price, R, Anstey, N, Yeo, T